المؤلفون: Radha K. Dhiman, Ajay Duseja, Akash Roy, Sunil Taneja, Mmphcrf Investigators, Madhumita Premkumar, Sanjeev Arora, Gagandeep Singh Grover

المصدر: EClinicalMedicine
EClinicalMedicine, Vol 41, Iss, Pp 101148-(2021)

مصطلحات موضوعية: hepatitis C virus, Medicine (General), Sofosbuvir, people who inject drugs, PWID, People Who Inject Drugs, DCV, Daclatasvir, chemistry.chemical_compound, injection drug use, CHC, chronic hepatitis C, Clinical endpoint, education.field_of_study, INASL, Indian National Association for study of the Liver, VEL, Velpatasvir, General Medicine, Hepatitis C, G, Genotype, DAAs, direct-acting antiviral agents, IDU, injection drug use, SVR, sustained virologic response, HCV, hepatitis C virus, HCV, DH, District Hospital, medicine.drug, Research Paper, Ledipasvir, medicine.medical_specialty, RBV, ribavirin, Daclatasvir, MMPHCRF, Mukh Mantri Punjab Hepatitis C Relief Fund, Population, India, LDV, ledipasvir, R5-920, ALT, alanine aminotransferase, ECHO, Extension for Community healthcare Outcome, medicine, NVHCP, National Viral Hepatitis Control Programme, education, Intention-to-treat analysis, business.industry, microelimination, medicine.disease, Discontinuation, CI, confidence interval, HBV, hepatitis B virus, chemistry, OST, opioid substitution therapy peg-interferon, SOF, sofosbuvir, Emergency medicine, business, HCC, hepatocellular carcinoma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b75aae0e46392eeae5fc474b6ba1cdf3
https://pubmed.ncbi.nlm.nih.gov/34712928